News

On April 3, 2026, the OPTN Board voted to appoint Steven Weitzen, JD, as a Board Director, filling the vacancy created by the passing of Peter Nicastro.

The OPTN Board of Directors announces the upcoming national election for the Board Officer positions of Secretary and Vice President of Patient and Donor Affairs.

These town halls will provide updates on the current state of the OPTN, as well as ongoing modernization efforts to strengthen the system and improve patient outcomes.

The Organ Procurement and Transplantation Network (OPTN), in collaboration with the Health Resources and Services Administration (HRSA), is notifying members that prior COVID-era guidance permitting the use of certain waitlist screening parameters to prevent organ offers is rescinded, effective immediately. 

A message from OPTN President John Magee acknowledging the challenges the OPTN Modernization effort is facing.

Effective March 25, 2026, the liver median MELD at transplant (MMaT) values have been updated for each donor hospital nationwide.

The OPTN Executive Committee approved the Membership and Professional Standards Committee’s (MPSC’s) recommendation to release Memorial Hermann Hospital, University of Texas at Houston (“Memorial Hermann”) from Member Not in Good Standing status.

OPTN Board approves removal of OPTN guidance on shortages of pediatric mechanical circulatory support devices and extends the HIV Open Variance

The OPTN is currently seeking nominations for individuals to serve on OPTN committees.

The Organ Procurement and Transplantation Network (OPTN) and Health Resources and Services Administration (HRSA) are committed to addressing organ allocation out of OPTN sequence (AOOS) in order to protect public trust, ensure adherence to OPTN policies, increase fairness, and uphold patient safety.